ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag federal funding immunology evolution

dual expresser t cell immunology type 1 diabetes
The Science News that Shaped 2019
Kerry Grens | Dec 20, 2019 | 6 min read
A T cell discovery, “hachimoji” DNA, a new species of human, and mounting fears of espionage rounded off the list this year.
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Notebook
The Scientist Staff | Jul 7, 1996 | 7 min read
On June 14, a House Appropriations subcommittee gave some researchers cause for celebration when it surprisingly voted to remove a provision in a government spending bill that extended a ban on federal funding of human embryo research. However, their glee was short-lived. The full panel turned around on June 25 and adopted an amendment to continue the research ban. John Eppig, senior staff scientist at Jackson Laboratory in Bar Harbor, Maine, doubts that the ban will be overturned anytime soon,
Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo
Enemies of the State
Alison McCook | Oct 1, 2006 | 2 min read
COURTESY OF LIBRARY OF CONGRESS, PRINTS AND PHOTOGRAPHS DIVISION Bush's isn't the only administration to use science selectively. Here's a sampling of previous incidents: Truman Subjected almost 60,000 federal scientists and those with access to classified information to security reviews, costing some clearances and work. Nixon Dissolved the office of the presidential science advisor. Asked candidate to head Nat
Observers Praise AIDS Report But Foresee Problems In Implementation
Steven Benowitz | May 12, 1996 | 10 min read
Problems In Implementation LOUD AND CLEAR: Attorney Lynda Dee stresses the need for communication among the institutes. When a federally appointed panel announced in March the results of its 15-month-long review of the United States government's AIDS research program, AIDS activists as well as scientists cheered. The National Institutes of Health's AIDS Research Program Evaluation Working Group's recommendations largely called for scrapping what the group saw as outdated and ineffective polic
Week in Review: December 15–19
Tracy Vence | Dec 18, 2014 | 2 min read
Reprogramming questioned; dengue-detecting antibodies; drug repurposing for Ebola; transcription of retroviruses
Organismal Biologists Get Organized
Karen Young Kreeger | Jun 11, 2000 | 4 min read
Organismal-level biologists from the more than 70 professional societies involved in the American Institute of Biological Sciences (AIBS) have recently come together to set common goals in such areas as policy and education. The process started last November when 57 leaders from the member societies gathered for the inaugural Presidents' Summit, the first event of its kind in AIBS's 53-year history. After an extended weekend of prioritizing and synthesizing ideas, the leaders identified 11 initi

Run a Search

ADVERTISEMENT